feed,title,long_url,short_url
BioRxiv,Sotrovimab retains activity against SARS-CoV-2 Omicron variant BQ.1.1 in a non-human primate model,https://biorxiv.org/cgi/content/short/2023.02.15.528538v1?rss=1,https://da.gd/d8bB
